ALK-Abelló A/S (ALK-B.CO) — Stock Score Summary

ALK-Abelló A/S (ALK-B.CO) has a MoatMap StockRank of 88/100 based on Quality (83/100), Value (18/100), and Momentum (73/100) factor scores. The current signal is STRONG BUY. ALK-Abelló is a high-quality global leader in allergy immunotherapy. While it possesses a strong moat and high ROIC, it does not align with our CDMO pricing power theme (as it is a proprietary specialty pharma, not a contract manufacturer) or any other active macro themes.

ALK-Abelló A/S is a global research-driven pharmaceutical company specializing in allergy immunotherapy, designed to treat the underlying cause of allergic diseases. The company is the undisputed market leader in sublingual allergy immunotherapy (SLIT) tablets, offering a comprehensive portfolio targeting grass, tree, ragweed, and house dust mite allergies. ALK's competitive moat is sustained by its complex biological manufacturing processes, extensive clinical trial data, and global regulatory approvals.

Key Financial Metrics

Price$41.98
Market Cap$9.3B
P/E (TTM)45.90
P/E (Forward)35.45
Price/Book8.98
Return on Equity20.9%
Return on Invested Capital21.6%
Debt/Equity6.24
Gross Margin67.9%
Operating Margin32.2%
Revenue Growth16.4%
Dividend Yield0.6%
Free Cash Flow$21M

ALK-Abelló A/S operates in the Biotechnology industry, part of the Healthcare sector (Denmark).

Frequently Asked Questions

What is ALK-Abelló A/S’s (ALK-B.CO) StockRank?
MoatMap’s StockRank for ALK-Abelló A/S (ALK-B.CO) is 88/100, with a Strong Buy signal. It is a composite of Quality (83), Value (18), and Momentum (73) factor ranks across MoatMap’s 19,000+ stock universe.
Does ALK-Abelló A/S have an economic moat?
ALK-Abelló A/S (ALK-B.CO) has a Quality factor score of 83/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is ALK-Abelló A/S a buy, hold, or sell?
MoatMap’s current signal for ALK-Abelló A/S (ALK-B.CO) is Strong Buy, based on a StockRank of 88/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is ALK-Abelló A/S in?
ALK-Abelló A/S (ALK-B.CO) operates in the Healthcare sector, specifically the Biotechnology industry (Denmark).
Browse all ranked stocksALK-B.CO deep dive reportAI ChampionsHow we score stocksSense-check another stock